
SOURCE:
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.
“It is exciting to see efficacy of potential new drugs for Dementia with Lewy Bodies, the most common dementia after Alzheimer’s. It is a huge area of unmet need,” said Dr. Marwan Sabbagh.
DIAGNOSIS VIDEO BY KHAN ACADEMY: There are many types of dementia. Vascular dementia, LBD, FTD and Parkinson’s Dementia are just a few. Dementia from alcoholism,
Researchers say reading, writing letters, doing puzzles or playing card games in later life could delay the onset of Alzheimer’s by as much as five years.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On